Applied DNA to Participate in Upcoming Conferences

Rhea-AI Summary

Applied DNA Sciences (NASDAQ: APDN) will participate in several upcoming virtual investor conferences. Key events include a company presentation by Dr. James A. Hayward at the H.C. Wainwright Global Life Sciences Virtual Conference on March 9-10, and a panel discussion at Roth Capital Markets’ 33rd Annual Conference on March 15. Additionally, Dr. Hayward will present at the Inaugural Emerging Growth Virtual Conference on March 17-19. These presentations will be accessible via the company’s website.

Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, will be participating in the following virtual investor conferences.

• March 9 – 10, 2021 – Dr. James A. Hayward, president and CEO, will present a company overview at the H.C. Wainwright Global Life Sciences Virtual Conference. Dr. Hayward and Beth Jantzen, chief financial officer, will also hold virtual investor meetings. Dr. Hayward’s pre-recorded presentation will be available for viewing beginning March 9 at 7:00 A.M. (ET). The presentation will also be available on Applied DNA’s website (link);
• March 15 – 17, 2021 – Dr. Hayward will participate on a virtual panel at Roth Capital Markets’ 33^rd Annual Conference titled ‘Therapeutics Against SARS-CoV-2 – Viral variants Will Not Fade Away’. The panel is scheduled for March 15, 2021 at 12:00pm ET and will be available to all Conference attendees, as well as on Applied DNA’s website (link). Management will also hold virtual investor meetings;
• March 17 – 19, 2021 – Dr. Hayward will present at the Inaugural Emerging Growth Virtual Conference presented by M Vest LLC and Maxim Group LLC. The presentation will be available to all registered participants of the conference (link) on March 17^th - 19^th and will be posted on Applied DNA’s website (link) after March 19.

About Applied DNA Sciences

Applied DNA is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping, and pre-clinical nucleic acid-based therapeutic drug candidates.

Visit adnas.com for more information. Follow us on Twitter and LinkedIn. Join our mailing list.

The Company’s common stock is listed on NASDAQ under ticker symbol ‘APDN’, and its publicly traded warrants are listed on OTC under ticker symbol ‘APPDW’.

Applied DNA is a member of the Russell Microcap® Index.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210308005635/en/

FAQ

What events is Applied DNA Sciences attending in March 2021?

Applied DNA Sciences will participate in multiple virtual conferences, including the H.C. Wainwright Global Life Sciences Virtual Conference (March 9-10), Roth Capital Markets’ 33rd Annual Conference (March 15), and the Inaugural Emerging Growth Virtual Conference (March 17-19).

Who will represent Applied DNA Sciences at these conferences?

Dr. James A. Hayward, president and CEO, and Beth Jantzen, chief financial officer, will represent Applied DNA Sciences at the upcoming virtual conferences.

When will Dr. Hayward's presentation be available for viewing?

Dr. Hayward's pre-recorded presentation for the H.C. Wainwright Global Life Sciences Virtual Conference will be available starting March 9 at 7:00 A.M. ET.

How can I access the presentations from Applied DNA Sciences?

The presentations from Applied DNA Sciences will be accessible on their official website following the conferences.

What is the stock symbol for Applied DNA Sciences?

The stock symbol for Applied DNA Sciences is APDN, and its warrants are listed under the symbol APPDW.